Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
bio
biology
crispr
harvard university alumni
jennifer doudna
living people
non-coding rna
repetitive dna sequences
1962 births
1963 births
american biochemists
american neuroscientists
american women scientists
berkeley college of chemistry faculty
biological engineering
biotechnology
broad institute
crystallographers
drama
editas medicine
emerging technologies
engineering disciplines
enzymes
genetic engineering
genetics
howard hughes medical investigators
massachusetts institute of technology faculty
members of the national academy of medicine
members of the united states national academy of sciences
molecular biology
stanford medical school alumni
synthetic biology
tc
university of california
university of california berkeley
women biochemists
yale department of molecular biophysics & biochemistry faculty
What
cas
3
×
crispr
doudna
3
×
jennifer
patent
3
×
berkeley
berkeley’s
editing
feng
gene
institute
inventor
read
rights
zhang
actually
appearance
argument
arguments
begin
broad
california
came
canceled
case
charpentier
colleague
competing
contender
court
date
december
decision
delighted
dispute
disputed
doudna’s
emmanuelle
favor
forward
Language
Current search:
cas
×
doudna
×
patent
×
@WIRED
7 years ago
Feng Zhang isn’t the villain in the Crispr/Cas9 patent dispute—not necessarily.
@techcrunch.com
7 years ago
CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month